Gapping up
In reaction to strong earnings/guidance: SIGM +7.6%, SURG +7.5%, OXM +7.4%, APIC +4.6%, TSM +0.9%, (May sales)
M&A news: HCC +36.1% (to be acquired by Tokio Marine Holdings for $78.00 in cash per share), CSG +5.2% (Bloomberg reporting CSG is considering sale and has received some interest in the company), JCI +5.1% (to explore strategic options for separation of automotive business)
Select metals/mining stocks trading higher metal futures up ~1% in pre-mkt: RIO +3.7%, GFI +3.1%, AG +2.9%, GOLD +2.9%, BHP +2.8%, CLF +2.8%, MT +2.5%, MTL +1.6%
Select oil/gas related names showing strength with crude and nat gas futures up 2% in pre-mkt: RIG +2.5%, EXC +2.4%, TOT +2.3%, WLL +2.3%, SDRL +2.2%, PBR +2.2%, FE +2.2%, SM +1.8%, RDS.A +1.7%, BP +1.6%
Other news: CYTX +10% (preclinical data for the Treatment of Thermal Injury published in the Journal Burns), CTIC +8.1% (disclosed an amendment to the Development, Commercialization and License Agreement with Baxter (BAX); milestone payments from BAX were accelerated), UACL +7.9% (announced the commencement of a modified "Dutch auction" tender offer to purchase up to 1 mln shares of its common stock), CANF +7.8% (announces a Notice of Allowance from the US PTO for a manufacturing method patent for its drug candidate CF101), BLDP +7% (signs a framework agreement with Tangshan Railway Vehicle Company for development of a new fuel cell module), WETF +5.8% (to replace QRVO in the S&P MidCap 400), OGXI+5.8% (FDA has agreed to the co's proposed amendment to the Phase 3 AFFINITY protocol and statistical analysis plan), XOMA +4.2% (treatment of congenital hyperinsulinism granted Orphan Drug Designation), QRVO +3.2% (to replace LO in the S&P 500), LBIO +3.2% (treatment of malignant melanoma Stages IIb to IV (tumor-inflitrating lymphocytes; LN-144) granted Orphan Drug Designation), STO +3% (elects Oystein Loseth as new Chairman), SPAN +2.9% (co has been selected as a supplier of consumer bedding products for the a major retailer's seasonal promotion in the fall of 2015), UVE +2.6% (announces the repurchase and retirement of Series M convertible preferred stock), UBS +2.6% (announces shares of UBS AG's to be delisted from SIX Swiss Exchange in H2 of 2015), FLT +2.5% (announces the signing of a contract with Uber to provide the Partner Fuel Card ), TTM +2.4% (Indian stocks to be included in MSCI EM Index in 2016), DB +1.6% (strong mkts in EU overnight), ABB +1.4% (strong mkts in EU overnight), ING +1.4% (exchanges EUR337.5 million notes of NN anchor investors into NN shares), ARIA+1.4% (granted Paladin Labs, an Endo International (ENDP) company, exclusive rights to distribute Iclusig in Canada for its newly approved indications), APAM +1.3% (announced May 2015 AUM of $111.6 bln), TGT +1.1% (confirms a 7.7% increase to its quarterly dividend to $0.56/share and a $5 bln expansion of its share repurchase authorization), NFLX +1.1% (investor group approves share split and associated additional shares, according to reports)
Analyst comments: CL +1.5% (upgraded to Hold from Sell at Societe Generale), HOV +1.4% (upgraded to Mkt Perform from Mkt Underperform at JMP Securities), NTAP +1.3% (upgraded to Outperform from Sector Perform at RBC Capital ), FGP +0.9% (upgraded to Neutral from Underweight at JP Morgan), JBHT +0.8% (upgraded to Outperform from Sector Perform at RBC Capital ), DG +0.8% (upgraded to Outperform from Sector Perform at RBC Capital)
In reaction to strong earnings/guidance: SIGM +7.6%, SURG +7.5%, OXM +7.4%, APIC +4.6%, TSM +0.9%, (May sales)
M&A news: HCC +36.1% (to be acquired by Tokio Marine Holdings for $78.00 in cash per share), CSG +5.2% (Bloomberg reporting CSG is considering sale and has received some interest in the company), JCI +5.1% (to explore strategic options for separation of automotive business)
Select metals/mining stocks trading higher metal futures up ~1% in pre-mkt: RIO +3.7%, GFI +3.1%, AG +2.9%, GOLD +2.9%, BHP +2.8%, CLF +2.8%, MT +2.5%, MTL +1.6%
Select oil/gas related names showing strength with crude and nat gas futures up 2% in pre-mkt: RIG +2.5%, EXC +2.4%, TOT +2.3%, WLL +2.3%, SDRL +2.2%, PBR +2.2%, FE +2.2%, SM +1.8%, RDS.A +1.7%, BP +1.6%
Other news: CYTX +10% (preclinical data for the Treatment of Thermal Injury published in the Journal Burns), CTIC +8.1% (disclosed an amendment to the Development, Commercialization and License Agreement with Baxter (BAX); milestone payments from BAX were accelerated), UACL +7.9% (announced the commencement of a modified "Dutch auction" tender offer to purchase up to 1 mln shares of its common stock), CANF +7.8% (announces a Notice of Allowance from the US PTO for a manufacturing method patent for its drug candidate CF101), BLDP +7% (signs a framework agreement with Tangshan Railway Vehicle Company for development of a new fuel cell module), WETF +5.8% (to replace QRVO in the S&P MidCap 400), OGXI+5.8% (FDA has agreed to the co's proposed amendment to the Phase 3 AFFINITY protocol and statistical analysis plan), XOMA +4.2% (treatment of congenital hyperinsulinism granted Orphan Drug Designation), QRVO +3.2% (to replace LO in the S&P 500), LBIO +3.2% (treatment of malignant melanoma Stages IIb to IV (tumor-inflitrating lymphocytes; LN-144) granted Orphan Drug Designation), STO +3% (elects Oystein Loseth as new Chairman), SPAN +2.9% (co has been selected as a supplier of consumer bedding products for the a major retailer's seasonal promotion in the fall of 2015), UVE +2.6% (announces the repurchase and retirement of Series M convertible preferred stock), UBS +2.6% (announces shares of UBS AG's to be delisted from SIX Swiss Exchange in H2 of 2015), FLT +2.5% (announces the signing of a contract with Uber to provide the Partner Fuel Card ), TTM +2.4% (Indian stocks to be included in MSCI EM Index in 2016), DB +1.6% (strong mkts in EU overnight), ABB +1.4% (strong mkts in EU overnight), ING +1.4% (exchanges EUR337.5 million notes of NN anchor investors into NN shares), ARIA+1.4% (granted Paladin Labs, an Endo International (ENDP) company, exclusive rights to distribute Iclusig in Canada for its newly approved indications), APAM +1.3% (announced May 2015 AUM of $111.6 bln), TGT +1.1% (confirms a 7.7% increase to its quarterly dividend to $0.56/share and a $5 bln expansion of its share repurchase authorization), NFLX +1.1% (investor group approves share split and associated additional shares, according to reports)
Analyst comments: CL +1.5% (upgraded to Hold from Sell at Societe Generale), HOV +1.4% (upgraded to Mkt Perform from Mkt Underperform at JMP Securities), NTAP +1.3% (upgraded to Outperform from Sector Perform at RBC Capital ), FGP +0.9% (upgraded to Neutral from Underweight at JP Morgan), JBHT +0.8% (upgraded to Outperform from Sector Perform at RBC Capital ), DG +0.8% (upgraded to Outperform from Sector Perform at RBC Capital)